FRINK Linked Data Fragments server

Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C2039> ?p ?o ?g. }

• NCIT_C2039 IAO_0000115 "A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine. Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels." @default.
• NCIT_C2039 NCIT_A32 NCIT_C1909 @default.
• NCIT_C2039 NCIT_A7 NCIT_C20450 @default.
• NCIT_C2039 NCIT_NHC0 "C2039" @default.
• NCIT_C2039 NCIT_P106 "Amino Acid, Peptide, or Protein" @default.
• NCIT_C2039 NCIT_P106 "Pharmacologic Substance" @default.
• NCIT_C2039 NCIT_P107 "Bevacizumab" @default.
• NCIT_C2039 NCIT_P108 "Bevacizumab" @default.
• NCIT_C2039 NCIT_P175 "704865" @default.
• NCIT_C2039 NCIT_P207 "C0796392" @default.
• NCIT_C2039 NCIT_P210 "216974-75-3" @default.
• NCIT_C2039 NCIT_P302 "Metastatic Colorectal Cancer, Non-small Cell Lung Cancer, glioblastoma; Metastatic Renal Cell Carcinoma; persistent, recurrent or metastatic cervical cancer; epithelial ovarian, fallopian tube, or primary peritoneal cancer" @default.
• NCIT_C2039 NCIT_P319 "2S9ZZM9Q9V" @default.
• NCIT_C2039 NCIT_P322 "CTRP" @default.
• NCIT_C2039 NCIT_P322 "FDA" @default.
• NCIT_C2039 NCIT_P322 "GDC" @default.
• NCIT_C2039 NCIT_P325 "A drug used to treat several types of cancer, including certain types of colorectal, lung, breast, and kidney cancers and glioblastoma. It is also being studied in the treatment of other types of cancer. Avastin binds to vascular endothelial growth factor (VEGF) and may prevent the growth of new blood vessels that tumors need to grow. It is a type of antiangiogenesis agent and a type of monoclonal antibody." @default.
• NCIT_C2039 NCIT_P329 "43234" @default.
• NCIT_C2039 NCIT_P330 "43234" @default.
• NCIT_C2039 NCIT_P366 "Bevacizumab" @default.
• NCIT_C2039 NCIT_P375 "Bevacizumab" @default.
• NCIT_C2039 NCIT_P399 "43234" @default.
• NCIT_C2039 NCIT_R124 NCIT_C17710 @default.
• NCIT_C2039 NCIT_R124 NCIT_C17828 @default.
• NCIT_C2039 NCIT_R124 NCIT_C18219 @default.
• NCIT_C2039 NCIT_R124 NCIT_C19986 @default.
• NCIT_C2039 NCIT_R124 NCIT_C40474 @default.
• NCIT_C2039 NCIT_R125 NCIT_C17133 @default.
• NCIT_C2039 NCIT_R125 NCIT_C17828 @default.
• NCIT_C2039 NCIT_R125 NCIT_C17932 @default.
• NCIT_C2039 NCIT_R125 NCIT_C18081 @default.
• NCIT_C2039 NCIT_R125 NCIT_C19143 @default.
• NCIT_C2039 NCIT_R125 NCIT_C20480 @default.
• NCIT_C2039 NCIT_R125 NCIT_C20751 @default.
• NCIT_C2039 NCIT_R125 NCIT_C21124 @default.
• NCIT_C2039 NCIT_R125 NCIT_C21128 @default.
• NCIT_C2039 NCIT_R125 NCIT_C21147 @default.
• NCIT_C2039 NCIT_R125 NCIT_C26044 @default.
• NCIT_C2039 NCIT_R125 NCIT_C40579 @default.
• NCIT_C2039 NCIT_R125 NCIT_C40821 @default.
• NCIT_C2039 NCIT_R146 NCIT_C126412 @default.
• NCIT_C2039 NCIT_R146 NCIT_C17021 @default.
• NCIT_C2039 NCIT_R146 NCIT_C20027 @default.
• NCIT_C2039 NCIT_R146 NCIT_C20424 @default.
• NCIT_C2039 NCIT_R146 NCIT_C20450 @default.
• NCIT_C2039 NCIT_R146 NCIT_C26548 @default.
• NCIT_C2039 NCIT_R72 NCIT_C12219 @default.
• NCIT_C2039 NCIT_R72 NCIT_C12508 @default.
• NCIT_C2039 NCIT_R72 NCIT_C12555 @default.
• NCIT_C2039 NCIT_R72 NCIT_C12865 @default.
• NCIT_C2039 NCIT_R72 NCIT_C21599 @default.
• NCIT_C2039 normalizedInformationContent "71.700606907059111" @default.
• NCIT_C2039 referenceCount "72" @default.
• NCIT_C2039 hasExactSynonym "ABP 215" @default.
• NCIT_C2039 hasExactSynonym "Anti-VEGF Humanized Monoclonal Antibody" @default.
• NCIT_C2039 hasExactSynonym "Anti-VEGF Monoclonal Antibody SIBP04" @default.
• NCIT_C2039 hasExactSynonym "Anti-VEGF rhuMAb" @default.
• NCIT_C2039 hasExactSynonym "Anti-VEGF" @default.
• NCIT_C2039 hasExactSynonym "Avastin" @default.
• NCIT_C2039 hasExactSynonym "BAT 1706" @default.
• NCIT_C2039 hasExactSynonym "BAT-1706" @default.
• NCIT_C2039 hasExactSynonym "BAT1706 Biosimilar" @default.
• NCIT_C2039 hasExactSynonym "BAT1706" @default.
• NCIT_C2039 hasExactSynonym "BEVACIZUMAB" @default.
• NCIT_C2039 hasExactSynonym "BP102 Biosimilar" @default.
• NCIT_C2039 hasExactSynonym "BP102" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar ABP 215" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar BAT1706" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar BEVZ92" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar BI 695502" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar CBT 124" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar CT-P16" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar FKB238" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar GB-222" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar HD204" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar HLX04" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar IBI305" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar LY01008" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar MIL60" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar MYL-1402O" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar Mvasi" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar QL 1101" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar QL1101" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar RPH-001" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar SCT501" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab Biosimilar Zirabev" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab awwb" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab-adcd" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab-awwb" @default.
• NCIT_C2039 hasExactSynonym "Bevacizumab-bvzr" @default.
• NCIT_C2039 hasExactSynonym "CT-P16" @default.
• NCIT_C2039 hasExactSynonym "HD204" @default.
• NCIT_C2039 hasExactSynonym "Immunoglobulin G1 (Human-Mouse Monoclonal rhuMab-VEGF Gamma-Chain Anti-Human Vascular Endothelial Growth Factor), Disulfide With Human-Mouse Monoclonal rhuMab-VEGF Light Chain, Dimer" @default.
• NCIT_C2039 hasExactSynonym "MYL-1402O" @default.
• NCIT_C2039 hasExactSynonym "Mvasi" @default.
• NCIT_C2039 hasExactSynonym "QL1101" @default.
• NCIT_C2039 hasExactSynonym "Recombinant Humanized Anti-VEGF Monoclonal Antibody" @default.
• NCIT_C2039 hasExactSynonym "SCT501" @default.
• NCIT_C2039 hasExactSynonym "SIBP 04" @default.

• next